Genomics

Dataset Information

0

HMVEC cells treated with vascular endothelial growth factor, anthrax edema toxin, and an Epac activator


ABSTRACT: Human microvascular endothelial cells (HMVEC) treated with vascular endothelial growth factor (VEGF), Antrhax Edema Toxin (ET), or the Epac activator, 8-pCPT-2'-O-Me-cAMP (8CPT) Human microvascular endothelial cells (HMVEC) were treated with VEGF alone or VEGF in combination with either the the Epac-specific cAMP-mimetic, 8-pCPT-2'-O-Me-cAMP (8CPT), or anthrax edema toxin (ET), an adenylyl cyclase. ET or 8CPT can inhibit VEGF-mediated chemotaxis and angiogenesis. The goal of the study was to identify genes regulated by cAMP production (ET) or by activation of Epac/Rap (8CPT) that may mitigate the effects of VEGF treatment.

ORGANISM(S): Homo sapiens

PROVIDER: GSE17777 | GEO | 2009/08/25

SECONDARY ACCESSION(S): PRJNA118285

REPOSITORIES: GEO

Similar Datasets

2009-09-13 | E-GEOD-17777 | biostudies-arrayexpress
| PRJNA118285 | ENA
2019-11-09 | GSE123907 | GEO
2019-11-09 | GSE123906 | GEO
2017-09-30 | GSE100095 | GEO
2008-06-16 | E-GEOD-9184 | biostudies-arrayexpress
2020-07-01 | GSE101201 | GEO
2007-09-28 | GSE9184 | GEO
| PRJNA510253 | ENA
2017-01-31 | GSE93696 | GEO